Trials / Recruiting
RecruitingNCT06026345
Affera Global Registry
The Affera Global Registry is a Prospective, Global, Multi-center, Observational Post-market Registry (PMR)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 540 (estimated)
- Sponsor
- Medtronic Cardiac Ablation Solutions · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Affera Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to describe clinical performance and safety data in a broad patient population treated with the Affera Platform.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Affera Platform | A cardiac ablation will be performed using the Affera Platform |
Timeline
- Start date
- 2023-12-22
- Primary completion
- 2028-04-01
- Completion
- 2028-07-01
- First posted
- 2023-09-07
- Last updated
- 2025-10-07
Locations
12 sites across 7 countries: Belgium, Czechia, France, Germany, Ireland, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT06026345. Inclusion in this directory is not an endorsement.